These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5016258)

  • 1. Specificity-determining site of -chymotrypsin. II. Inactivation of -chymotrypsin by aromatic diazonium compounds.
    Yoshida N; Ishii S
    J Biochem; 1972 Feb; 71(2):193-9. PubMed ID: 5016258
    [No Abstract]   [Full Text] [Related]  

  • 2. Specificity-determining site of -chymotrypsin. I. Kinetic investigation of aromatic amino compounds and phenylalanine ester derivatives in -chymotrypsin-catalyzed hydrolysis.
    Yoshida N; Ishii S
    J Biochem; 1972 Feb; 71(2):185-91. PubMed ID: 5016257
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificity-determining site of alpha-chymotrypsin. 3. Inactivation of alpha-chymotrypsin by p-diazo-N-acetyl-L-phenylalanine methyl ester.
    Yoshida N; Yamasaki M; Ishii S
    J Biochem; 1973 Jun; 73(6):1175-83. PubMed ID: 4724294
    [No Abstract]   [Full Text] [Related]  

  • 4. Calorimetric investigations of the binding of inhibitors to alpha-chymotrypsin. II. A systematic comparison of the thermodynamic functions of binding of a variety of inhibitors to alpha-chymotrypsin.
    Shiao DD
    Biochemistry; 1970 Mar; 9(5):1083-90. PubMed ID: 5418709
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of the catalytic properties of alpha-chymotrypsin by chemical modification at Tyr 146.
    Gorecki M; Wilchek M; Blumberg S
    Biochim Biophys Acta; 1978 Jul; 535(1):90-9. PubMed ID: 667120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photolytic inhibition and labeling of proteins with aryl diazonium compounds.
    Tometsko AM; Turula J; Comstock J
    Int J Pept Protein Res; 1978 Sep; 12(3):143-54. PubMed ID: 29842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low pH dimerization behavior of active-site derivatives of bovine -chymotrypsin.
    Horbett TA; Teller DC
    Biochemistry; 1973 Mar; 12(7):1349-58. PubMed ID: 4735302
    [No Abstract]   [Full Text] [Related]  

  • 8. Haloenol lactones: enzyme-activated irreversible inactivators for serine proteases. Inactivation of alpha-chymotrypsin.
    Chakravarty PK; Krafft GA; Katzenellenbogen JA
    J Biol Chem; 1982 Jan; 257(2):610-2. PubMed ID: 7054169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and activity of two photoreversible cinnamates bound to chymotrypsin.
    Stoddard BL; Bruhnke J; Porter N; Ringe D; Petsko GA
    Biochemistry; 1990 May; 29(20):4871-9. PubMed ID: 2364065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenothiazine-N-carbonyl chloride, a specific inactivator of chymotrypsin.
    Erlanger BF; Vratsanos SM; Wassermann NH; Cooper AG
    Biochem J; 1970 Jul; 118(3):421-5. PubMed ID: 5472167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conformational change in the benzeneboronic acid-alpha-chymotrypsin complex. Evidence for a conformational change in a tetrahedral adduct of alpha-chymotrypsin.
    Hanai K
    J Biochem; 1977 May; 81(5):1273-83. PubMed ID: 197063
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of inactivation of alpha-chymotrypsin with substituted benzenesulfonyl fluorides.
    Gerig JT; Roe DC
    J Am Chem Soc; 1974 Jan; 96(1):233-8. PubMed ID: 4810568
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective inactivation of serine proteases by nonheme iron complexes.
    Prakash J; Kodanko JJ
    Inorg Chem; 2011 May; 50(9):3934-45. PubMed ID: 21469655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of surface and macromolecular interactions on the kinetics of inactivation of trypsin and alpha-chymotrypsin.
    Johnson P; Whateley TL
    Biochem J; 1981 Jan; 193(1):285-94. PubMed ID: 6272706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
    Baker BR; Hurlbut JA
    J Med Chem; 1969 Jan; 12(1):118-22. PubMed ID: 5763006
    [No Abstract]   [Full Text] [Related]  

  • 16. Thermodynamics of alpha-chymotrypsin-inhibitor complex formation. Effects of structural modification of the inhibitor.
    Hymes AJ; Cuppett CC; Canady WJ
    J Biol Chem; 1969 Feb; 244(4):637-43. PubMed ID: 5768861
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetic manifestations of the structure of the active center of -chymotrypsin on interacting with fragments of specific substrates.
    Martinek K; Varfolomeev SD; Levashov AV; Berezin IV
    Mol Biol; 1971; 5(3):278-86. PubMed ID: 5154822
    [No Abstract]   [Full Text] [Related]  

  • 18. Reaction of lentil trypsin-chymotrypsin inhibitors with human and bovine proteinases.
    Weder JK; Kahleyss R
    J Agric Food Chem; 2003 Dec; 51(27):8045-50. PubMed ID: 14690394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of enzyme thermostability and its surface hydrophobicity (using a modified alpha-chymotrypsin as an example)].
    Melik-Nubarov NS; Shikshnis VA; Slepnev VI; Shchegolev AA; Mozhaev VV
    Mol Biol (Mosk); 1990; 24(2):346-57. PubMed ID: 2362586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of neutral subtilopeptidase by aromatic diazo compounds.
    Fujiwara K; Tsuru D
    Int J Pept Protein Res; 1973; 5(6):447-53. PubMed ID: 4205761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.